Painkiller in the dock

    Article metrics

    Still reeling from the loss of its blockbuster pill Vioxx, Merck is now in court to face its first lawsuit over the drug. Meredith Wadman reports.

    Access options

    Rent or Buy article

    Get time limited or full article access on ReadCube.

    from$8.99

    All prices are NET prices.

    Related links

    Related links

    Related links in Nature Research

    Drug safety on trial

    Drug safety special: The safety catch

    Vioxx may go back on sale after scraping past FDA panel

    Related external links

    Merck

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Painkiller in the dock. Nature 436, 459 (2005) doi:10.1038/436459a

    Download citation

    Further reading

    Comments

    By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.